Bioharvest Sciences Inc. balance sheet

At the end of fiscal 2025, Bioharvest Sciences Inc. had shareholders' equity of $25.4m. It held $23.0m in cash against $149,000 of debt: net cash of $22.9m.

Balance sheet

US$ millions unless shown otherwise. Fiscal years, plus the last twelve months (LTM) when newer.

Bioharvest Sciences Inc.: balance sheet, annual
Fiscal year	2023Dec 2023	2024Dec 2024	2025Dec 2025
Cash and equivalents	5	2	23
Receivables	1	1	2
Inventory	2	4	5
Total current assets	9	8	31
Accounts payable	2	4	3
Total current liabilities	26	14	8
Short-term debt	0	4	0
Total debt	21	4	0
Shareholders' equity	−15	1	25
Net debt (negative = net cash)	15	2	−23

Balances at each fiscal year end (quarter end in the quarterly view). Total debt is short- plus long-term borrowings, including lease debt where the company reports it within debt. Where assets do not equal liabilities plus shareholders' equity, the difference (non-controlling interests, redeemable preferred shares) is shown on its own line.

Compare with peers

Head to head: BHST vs VYGR BHST vs CCCC BHST vs FHTX

More: Biotechnology stocks compared, Health Care sector, rankings of US companies

Figures from Bioharvest Sciences Inc.'s SEC filings (10-K and 10-Q). How we read and check them: methodology and data sources. Not investment advice. Back to Bioharvest Sciences Inc.